Suchergebnisse - "Luo, Zhangyi"

PubPharm (16)

1

Knocking down of Xkr8 enhances chemotherapy efficacy through modulating tumor immune microenvironment

enthalten in: Journal of controlled release : official journal of the Controlled Release Society | 2024

von Chen, Y. | Chen, C. | Huang, H. | +4

2

In Situ Formation of Fibronectin-Enriched Protein Corona on Epigenetic Nanocarrier for Enhanced Synthetic Lethal Therapy

enthalten in: Advanced science (Weinheim, Baden-Wurttemberg, Germany) | 2024

von Luo, Z. | Wan, Z. | Ren, P. | +10

3

Knocking down of Xkr8 enhances chemotherapy efficacy through modulating tumor immune microenvironment

enthalten in: Journal of controlled release : official journal of the Controlled Release Society | 2024

von Chen, Y. | Chen, C. | Huang, H. | +4

4

Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy

enthalten in: Nature communications | 2024

von Luo, Z. | Huang, Y. | Batra, N. | +15

5

Targeting cancer metabolic pathways for improving chemotherapy and immunotherapy

enthalten in: Cancer letters | 2023

von Luo, Z. | Eichinger, K. | Zhang, A. | +1

6

Targeting Xkr8 via nanoparticle-mediated in situ co-delivery of siRNA and chemotherapy drugs for cancer immunochemotherapy

enthalten in: Nature nanotechnology | 2023

von Chen, Y. | Huang, Y. | Li, Q. | +10

7

Overcoming pancreatic cancer immune resistance by codelivery of CCR2 antagonist using a STING-activating gemcitabine-based nanocarrier

enthalten in: Materials today (Kidlington, England) | 2023

von Wan, Z. | Huang, H. | West, R. | +13

8

Improved antitumor activity against prostate cancer via synergistic targeting of Myc and GFAT-1

enthalten in: Theranostics | 2023

von Zhang, Y. | Li, J. | Huang, Y. | +7

9

Engineering a folic acid-decorated ultrasmall gemcitabine nanocarrier for breast cancer therapy : Dual targeting of tumor cells and tumor-associated macrophages

enthalten in: Acta pharmaceutica Sinica. B | 2022

von Moharil, P. | Wan, Z. | Pardeshi, A. | +10

10

Farnesylthiosalicylic acid-derivatized PEI-based nanocomplex for improved tumor vaccination

enthalten in: Molecular therapy. Nucleic acids | 2021

von Chen, Y. | Huang, Y. | Huang, H. | +7